Automatic Mitosis and Nuclear Atypia Detection for Breast Cancer Grading in Histopathological Images using Hybrid Machine Learning Technique

被引:0
作者
Maheshwari N.U. [1 ]
SatheesKumaran S. [1 ]
机构
[1] Department of Electronics and Communication Engineering, Anurag Group of Institutions, Telangana, Ghatkesar
关键词
Breast cancer grading; Feature extraction; Feature selection; Mitosis cell; Nuclear atypia score; Segmentation;
D O I
10.1007/s11042-023-18078-8
中图分类号
学科分类号
摘要
Invasive breast cancer is a complex global health issue and the leading cause of women's mortality. Multiclassification in breast cancer, especially with high-resolution images, presents unique challenges. Clinical diagnosis relies on the cancer's pathological stage, requiring precise segmentation and adjustments. Complex structural changes during slide preparation and inconsistent image magnifications further complicate classification. To address these challenges, we propose a hybrid machine learning framework for accurate breast cancer detection and grading using large-scale pathological images. Our approach includes an improved Non-restricted Boltzmann Deep Belief Neural Network for nuclei segmentation, followed by feature extraction and novel feature selection using the Giraffe Kicking Optimization algorithm to mitigate overfitting. We implement an Optimal Kernel layer-based Support Vector Machine classifier to identify mitotic cells and nuclear atypia, using the Nottingham Grading System. Validation on the MITOSIS-ATYPIA-14 database demonstrates the framework's effectiveness, with performance metrics including accuracy, precision, recall, specificity, and F-measure. This approach addresses the complexities of breast cancer classification and grading in a streamlined manner, enhancing diagnostic accuracy and prognosis prediction. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
引用
收藏
页码:90105 / 90132
页数:27
相关论文
共 40 条
[1]  
Buumba B.M., Bhardwaj S., Kaur P., A critical review on recent development of techniques and drug targets in the management of breast cancer, Mini Rev Med Chem, 21, 15, pp. 2103-2129, (2021)
[2]  
Kaur G., Gupta R., Hooda N., Gupta N.R., Machine learning techniques and breast cancer prediction: A review, Wirel Personal Commun, 125, 3, pp. 2537-2564, (2022)
[3]  
Manju A., Arivukarasi M., Mahasree M., AEDAMIDL: An Enhanced and Discriminant Analysis of Medical Images using Deep Learning, In 2022 Third International Conference on Smart Technologies in Computing, Electrical and Electronics (ICSTCEE) 1–8. IEEE, (2022)
[4]  
Sonik D., Colarossi A., Becoming Artificial: A Philosophical Exploration Into Artificial Intelligence and what it Means to be Human. Vol. 73, Andrews UK Limited, (2020)
[5]  
Ry H., Elasticity Mapping for Breast Cancer Diagnosis Using Tactile Imaging and Auxiliary Sensor Fusion, (2021)
[6]  
Moroni S., Casettari L., Lamprou D.A., 3D and 4D Printing in the Fight against Breast Cancer, Biosensors, 12, 8, (2022)
[7]  
Elumalai S., Manago S., Luca A.C.D., Raman microscopy: progress in research on cancer cell sensing, Sensors, 20, 19, (2020)
[8]  
Shahbandi A., Chiu F.-Y., Ungerleider N.A., Kvadas R., Mheidly Z., Sun M.J.S., Tian D., Et al., Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80, Nat Cancer, 3, 12, pp. 1513-1533, (2022)
[9]  
Kushwah V.S., Saxena A., Pahariya J.S., Kumar S.G., Support Vector Machine Technique to Prognosis Breast Cancer, Soft Computing: Theories and Applications: Proceedings of Socta 2020, 2, pp. 339-351, (2021)
[10]  
Gurinderchaturvedi S., Shrivastava P., Vikram Singh A.S., Breast Cancer Screening Using Machine Learning Models, 2022 3Rd International Conference on Intelligent Engineering and Management (ICIEM), pp. 961-967, (2022)